Search

everythinglearnresearchcommunity

for

Search:↓

Placebo effects in alopecia treatments are likely due to study design, not real improvement.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Inositol was not more effective than a placebo in treating trichotillomania.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Minoxidil use increases facial hair growth in females, more in older users.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Minoxidil helps hair growth in people with monilethrix without side effects.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Minoxidil helps hair growth and prevents hair loss in androgenetic alopecia. It's safe and effective.

Topical minoxidil effectively treats male pattern baldness and prevents hair loss.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.